Eyelash Trichomegaly Complicating Pembrolizumab for Colorectal Cancer

    Nektarios Alevizopoulos, Dimitrios Alexandris
    Studysummary This case study reports a rare instance of pembrolizumab-induced eyelash trichomegaly in a 63-year-old male patient, highlighting the importance for clinicians to be aware of such uncommon adverse effects to manage patient treatment effectively.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Eyelash Trichomegaly: Unusual Feature Associated With Systemic Lupus Erythematosus Patient Case reports in medicine · 2022
    2. Persistently Curly Hair Phenotype With the Use of Nivolumab for Squamous Cell Lung Cancer Journal of oncology pharmacy practice · 2016
    3. Biology of the Eyelash Hair Follicle: An Enigma in Plain Sight British journal of dermatology/British journal of dermatology, Supplement · 2015
    4. Eyelash Trichomegaly: Review of Congenital, Acquired, and Drug-Associated Etiologies for Elongation of the Eyelashes International Journal of Dermatology · 2012
    5. Cetuximab-Associated Elongation of the Eyelashes American Journal of Clinical Dermatology · 2010
    6. Persistent Hair Growth During Treatment With the EGFR Inhibitor Erlotinib Dermatology Online Journal · 2009

    Related research 2

    1. Acitretin-Induced Alopecia Areata: A Case Report Cutaneous and ocular toxicology · 2014
    2. Enhancing the Growth of Natural Eyelashes: The Mechanism of Bimatoprost-Induced Eyelash Growth Dermatologic Surgery · 2010